Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
October 2019 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytical
In 2019, we have seen a variety of workers’ compensation tre
With the end of 2019 rapidly approaching, it is only natural to start thinking about the year ahead.
This article is authored by guest blogger, Deborah Robinson Stewart, National Manager of Medicare Set-Asides, Genex Services. In its simpl
Keep current with new legislation and its potential effect on your organization.
Keep current with new legislation and its potential effect on your organization.